e-learning
resources
Virtual 2020
Pre-Congress Content
Non-tuberculous mycobacterial infections and bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are COPD patients with Nocardia species identification different from those who have also co-morbid bronchiectasis?
M. Serino (Braga, Portugal), C. Sousa (Porto, Portugal), M. Redondo (Porto, Portugal), N. Martins (Porto, Portugal), A. Amorim (Porto, Portugal)
Source:
Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Session:
Non-tuberculous mycobacterial infections and bronchiectasis
Session type:
E-poster session
Number:
2367
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Serino (Braga, Portugal), C. Sousa (Porto, Portugal), M. Redondo (Porto, Portugal), N. Martins (Porto, Portugal), A. Amorim (Porto, Portugal). Are COPD patients with Nocardia species identification different from those who have also co-morbid bronchiectasis?. 2367
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Impact of comorbid bronchiectasis on COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Prevalence of bronchiectasis in stable COPD outpatients
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004
Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Bronchiectasis prevalence and relationship with clinical features in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence?
Source: Eur Respir J 2002; 19: 387-389
Year: 2002
A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Pseudomonas aeruginosa
drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001
Analysis of microbiological colonization in COPD patients with or without bronchiectasis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Non-CF bronchiectasis, an obstructive disease. Similarities with COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
High mortality in COPD patients with isolation of
aspergillus spp
in bronchial secretions
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept